Advertisement

GeroScience

pp 1–16 | Cite as

Sulfoaphane - role in aging and neurodegeneration

  • Roberto Santín-Márquez
  • Adriana Alarcón-Aguilar
  • Norma Edith López-Diazguerrero
  • Niki Chondrogianni
  • Mina KönigsbergEmail author
Original Article

Abstract

In the last several years, numerous molecules derived from plants and vegetables have been tested for their antioxidant, anti-inflammatory, and anti-aging properties. One of them is sulforaphane (SFN), an isothiocyanate present in cruciferous vegetables. SFN activates the antioxidant and anti-inflammatory responses by inducing Nrf2 pathway and inhibiting NF-κB. It also has an epigenetic effect by inhibiting HDAC and DNA methyltransferases and modifies mitochondrial dynamics. Moreover, SFN preserves proteome homeostasis (proteostasis) by activating the proteasome, which has been shown to lead to increased cellular lifespan and prevent neurodegeneration. In this review, we describe some of the molecular and physical characteristics of SFN, its mechanisms of action, and the effects that SFN treatment induces in order to discuss its relevance as a “miraculous” drug to prevent aging and neurodegeneration.

Keywords

Proteasome Oxidative stress Nrf2 NF-κB HDAC 

Notes

Funding information

This work was supported by CONACyT grant FON.INST/298/2016, as well as the “Red Temática de Investigación en Salud y Desarrollo Social” from CONACYT, Mexico. Santín-Márquez is a CONACyT scholarship holder. Research from NC lab is currently co-financed by the European Union and Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, (a) under the call RESEARCH – CREATE – INNOVATE (project code: T1EDK-00353 and T1EDK-01610) and (b) under the Action “Action for the Strategic Development on the Research and Technological Sector” (project STHENOS-b, MIS 5002398).

References

  1. Alfieri A, Srivastava S, Siow RC, Cash D, Modo M, Duchen MR, … Mann GE (2013) Sulforaphane preconditioning of the Nrf2/HO-1 defense pathway protects the cerebral vasculature against blood–brain barrier disruption and neurological deficits in stroke. Free Radic Biol Med 65:1012–1022Google Scholar
  2. Angelino D, Jeffery E (2014) Glucosinolate hydrolysis and bioavailability of resulting isothiocyanates: focus on glucoraphanin. J Funct Foods 7:67–76CrossRefGoogle Scholar
  3. Atwell LL, Hsu A, Wong CP, Stevens JF, Bella D, Yu TW, … Dashwood RH (2015) Absorption and chemopreventive targets of sulforaphane in humans following consumption of broccoli sprouts or a myrosinase-treated broccoli sprout extract. Mol Nutr Food Res 59(3):424–433Google Scholar
  4. Bai Y, Cui W, Xin Y, Miao X, Barati MT, Zhang C et al (2013) Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation. J Mol Cell Cardiol 57:82–95CrossRefPubMedGoogle Scholar
  5. Barba FJ, Nikmaram N, Roohinejad S, Khelfa A, Zhu Z, Koubaa M (2016) Bioavailability of glucosinolates and their breakdown products: impact of processing. Front Nutr 3:24CrossRefPubMedPubMedCentralGoogle Scholar
  6. Bhakkiyalakshmi E, Sireesh D, Rajaguru P, Paulmurugan R, Ramkumar KM (2015) The emerging role of redox-sensitive Nrf2–Keap1 pathway in diabetes. Pharmacol Res 91:104–114CrossRefPubMedGoogle Scholar
  7. Bheemreddy RM, Jeffery EH (2007) The metabolic fate of purified glucoraphanin in F344 rats. J Agric Food Chem 55(8):2861–2866CrossRefPubMedGoogle Scholar
  8. Bones AM, Rossiter JT (2006) The enzymic and chemically induced decomposition of glucosinolates. Phytochemistry 67(11):1053–1067CrossRefPubMedGoogle Scholar
  9. Bricker GV, Riedl KM, Ralston RA, Tober KL, Oberyszyn TM, Schwartz SJ (2014) Isothiocyanate metabolism, distribution, and interconversion in mice following consumption of thermally processed broccoli sprouts or purified sulforaphane. Mol Nutr Food Res 58(10):1991–2000CrossRefPubMedPubMedCentralGoogle Scholar
  10. Brown AF, Yousef GG, Jeffery EH, Klein BP, Wallig MA, Kushad MM, Juvik JA (2002) Glucosinolate profiles in broccoli: variation in levels and implications in breeding for cancer chemoprotection. J Am Soc Hortic Sci 127(5):807–813CrossRefGoogle Scholar
  11. Budenholzer L, Cheng CL, Li Y, Hochstrasser M (2017) Proteasome structure and assembly. J Mol Biol 429(22):3500–3524CrossRefPubMedPubMedCentralGoogle Scholar
  12. Burmeister WP, Cottaz S, Rollin P, Vasella A, Henrissat B (2000) High resolution X-ray crystallography shows that ascorbate is a cofactor for myrosinase and substitutes for the function of the catalytic base. J Biol Chem 275:39385–39393CrossRefPubMedGoogle Scholar
  13. Campisi J, di Fagagna F d A (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8(9):729–740CrossRefPubMedGoogle Scholar
  14. Chapple SJ, Siow RC, Mann GE (2012) Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging. Int J Biochem Cell Biol 44(8):1315–1320CrossRefPubMedPubMedCentralGoogle Scholar
  15. Checker R, Gambhir L, Thoh M, Sharma D, Sandur SK (2015) Sulforaphane, a naturally occurring isothiocyanate, exhibits anti-inflammatory effects by targeting GSK3β/Nrf-2 and NF-κB pathways in T cells. J Funct Foods 19:426–438CrossRefGoogle Scholar
  16. Childs BG, Durik M, Baker DJ, Van Deursen JM (2015) Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med 21(12):1424–1435CrossRefPubMedPubMedCentralGoogle Scholar
  17. Chondrogianni N, Gonos ES (2007) Overexpression of hUMP1/POMP proteasome accessory protein enhances proteasome-mediated antioxidant defence. Exp Gerontol 42(9):899–903CrossRefPubMedGoogle Scholar
  18. Chondrogianni N, Petropoulos I, Franceschi C, Friguet B, Gonos ES (2000) Fibroblast cultures from healthy centenarians have an active proteasome. Exp Gerontol 35(6–7):721–728CrossRefPubMedGoogle Scholar
  19. Chondrogianni N, Stratford FL, Trougakos IP, Friguet B, Rivett AJ, Gonos ES (2003) Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. J Biol Chem 278:28026–28037CrossRefPubMedGoogle Scholar
  20. Chondrogianni N, Tzavelas C, Pemberton AJ, Nezis IP, Rivett AJ, Gonos ES (2005) Overexpression of proteasome β5 subunit increases amount of assembled proteasome and confers ameliorated response to oxidative stress and higher survival rates. J Biol Chem 280:11840–11850CrossRefPubMedGoogle Scholar
  21. Chondrogianni N, Trougakos IP, Kletsas D, Chen QM, Gonos ES (2008) Partial proteasome inhibition in human fibroblasts triggers accelerated M1 senescence or M2 crisis depending on p53 and Rb status. Aging Cell 7(5):717–732CrossRefPubMedGoogle Scholar
  22. Chondrogianni N, Voutetakis K, Kapetanou M, Delitsikou V, Papaevgeniou N, Sakellari M, Lefaki M, Filippopoulou K, Gonos ES (2015) Proteasome activation: an innovative promising approach for delaying aging and retarding age-related diseases. Ageing Res Rev 23:37–55CrossRefPubMedGoogle Scholar
  23. Chondrogianni N, Georgila K, Kourtis N, Tavernarakis N, Gonos ES (2015a) 20S proteasome activation promotes life span extension and resistance to proteotoxicity in Caenorhabditis elegans. FASEB J 29(2):611–622CrossRefPubMedGoogle Scholar
  24. Chondrogianni N, Sakellari M, Lefaki M, Papaevgeniou N, Gonos ES (2015b) Proteasome activation delays aging in vitro and in vivo. Free Radic Biol Med 71:303–320CrossRefGoogle Scholar
  25. Ciechanover A (1998) The ubiquitin–proteasome pathway: on protein death and cell life. EMBO J 17(24):7151–7160CrossRefPubMedPubMedCentralGoogle Scholar
  26. Clarke JD, Hsu A, Williams DE, Dashwood RH, Stevens JF, Yamamoto M, Ho E (2011) Metabolism and tissue distribution of sulforaphane in Nrf2 knockout and wild-type mice. Pharm Res 28(12):3171–3179CrossRefPubMedPubMedCentralGoogle Scholar
  27. Colditz GA, Branch LG, Lipnick RJ, Willett WC, Rosner B, Posner BM, Hennekens CH (1985) Increased green and yellow vegetable intake and lowered cancer deaths in an elderly population. Am J Clin Nutr 41(1):32–36.  https://doi.org/10.1093/ajcn/41.1.32 CrossRefPubMedGoogle Scholar
  28. Cramer JM, Jeffery EH (2011) Sulforaphane absorption and excretion following ingestion of a semi-purified broccoli powder rich in glucoraphanin and broccoli sprouts in healthy men. Nutr Cancer 63(2):196–201CrossRefPubMedGoogle Scholar
  29. Dai D-F, Chiao YA, Marcinek DJ, Szeto HH, Rabinovitch PS (2014) Mitochondrial oxidative stress in aging and healthspan. Longev Healthspan 3(1):6CrossRefPubMedPubMedCentralGoogle Scholar
  30. Daniel M, Tollefsbol TO (2015) Epigenetic linkage of aging, cancer and nutrition. J Exp Biol 218(1):59–70CrossRefPubMedPubMedCentralGoogle Scholar
  31. Dashwood RH, Ho E (2008) Dietary agents as histone deacetylase inhibitors: sulforaphane and structurally related isothiocyanates. Nutr Rev 66:S36–S38CrossRefPubMedPubMedCentralGoogle Scholar
  32. Dinkova-Kostova AT, Fahey JW, Kostov RV, Kensler TW (2017) KEAP1 and done? Targeting the NRF2 pathway with sulforaphane. Trends Food Sci Technol 69:257–269CrossRefPubMedPubMedCentralGoogle Scholar
  33. Dwivedi S, Rajasekar N, Hanif K, Nath C, Shukla R (2016) Sulforaphane ameliorates okadaic acid-induced memory impairment in rats by activating the Nrf2/HO-1 antioxidant pathway. Mol Neurobiol 53(8):5310–5323CrossRefPubMedGoogle Scholar
  34. Fahey J, Talalay P (1999) Antioxidant functions of sulforaphane: a potent inducer of phase II detoxication enzymes. Food Chem Toxicol 37(9–10):973–979CrossRefPubMedGoogle Scholar
  35. Fishbein JC, Heilman JM (2018) Advances in molecular toxicology. Elsevier ScienceGoogle Scholar
  36. Gabriel D, Roedl D, Gordon LB, Djabali K (2015) Sulforaphane enhances progerin clearance in Hutchinson–Gilford progeria fibroblasts. Aging Cell 14(1):78–91CrossRefPubMedGoogle Scholar
  37. Gan N, Wu Y-C, Brunet M, Garrido C, Chung F-L, Dai C, Mi L (2010) Sulforaphane activates heat shock response and enhances proteasome activity through up-regulation of Hsp27. J Biol Chem 285(46):35528–35536CrossRefPubMedPubMedCentralGoogle Scholar
  38. Gao J, Xiong B, Zhang B, Li S, Huang N, Zhan G et al (2018) Sulforaphane alleviates lipopolysaccharide-induced spatial learning and memory dysfunction in mice: the role of BDNF-mTOR signaling pathway. Neuroscience 388:357–366CrossRefPubMedGoogle Scholar
  39. Ghawi SK, Methven L, Niranjan K (2013) The potential to intensify sulforaphane formation in cooked broccoli (Brassica oleracea var. italica) using mustard seeds (Sinapis alba). Food Chem 138(2–3):1734–1741CrossRefPubMedGoogle Scholar
  40. Gordon LB, Rothman FG, López-Otín C, Misteli T (2014) Progeria: a paradigm for translational medicine. Cell 156(3):400–407CrossRefPubMedPubMedCentralGoogle Scholar
  41. Greco T, Shafer J, Fiskum G (2011) Sulforaphane inhibits mitochondrial permeability transition and oxidative stress. Free Radic Biol Med 51(12):2164–2171CrossRefPubMedPubMedCentralGoogle Scholar
  42. Grünwald S, Stellzig J, Adam IV, Weber K, Binger S, Boll M, Knorr E, Twyman RM, Vilcinskas A, Wenzel U (2013) Longevity in the red flour beetle Tribolium castaneum is enhanced by broccoli and depends on nrf-2, jnk-1 and foxo-1 homologous genes. Genes Nutr 8(5):439–448CrossRefPubMedPubMedCentralGoogle Scholar
  43. Guerrero-Beltrán CE, Calderón-Oliver M, Pedraza-Chaverri J, Chirino YI (2012) Protective effect of sulforaphane against oxidative stress: recent advances. Exp Toxicol Pathol 64(5):503–508CrossRefPubMedGoogle Scholar
  44. Guo L, Yang R, Wang Z, Guo Q, Gu Z (2014) Glucoraphanin, sulforaphane and myrosinase activity in germinating broccoli sprouts as affected by growth temperature and plant organs. J Funct Foods 9:70–77CrossRefGoogle Scholar
  45. Hanlon N, Coldham N, Gielbert A, Kuhnert N, Sauer MJ, King LJ, Ioannides C (2008) Absolute bioavailability and dose-dependent pharmacokinetic behaviour of dietary doses of the chemopreventive isothiocyanate sulforaphane in rat. Br J Nutr 99(3):559–564CrossRefPubMedGoogle Scholar
  46. Hariton F, Xue M, Rabbani N, Fowler M, Thornalley PJ (2018) Sulforaphane delays fibroblast senescence by curbing cellular glucose uptake, increased glycolysis, and oxidative damage. Oxidative Med Cell LongevGoogle Scholar
  47. Heiss E, Herhaus C, Klimo K, Bartsch H, Gerhauser C (2001) Nuclear factor-κB is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J Biol Chem 276:32008–32015CrossRefPubMedGoogle Scholar
  48. Hernandez-Rabaza V, Cabrera-Pastor A, Taoro-Gonzalez L, Gonzalez-Usano A, Agusti A, Balzano T et al (2016) Neuroinflammation increases GABAergic tone and impairs cognitive and motor function in hyperammonemia by increasing GAT-3 membrane expression. Reversal by sulforaphane by promoting M2 polarization of microglia. J Neuroinflammation 13(1):83CrossRefPubMedPubMedCentralGoogle Scholar
  49. Hou T-T, Yang H-Y, Wang W, Wu Q-Q, Tian Y-R, Jia J-P (2018) Sulforaphane inhibits the generation of amyloid-β oligomer and promotes spatial learning and memory in Alzheimer’s disease (PS1V97L) transgenic mice. J Alzheimers Dis (preprint) 1–11Google Scholar
  50. Hsu A, Wong CP, Yu Z, Williams DE, Dashwood RH, Ho E (2011) Promoter de-methylation of cyclin D2 by sulforaphane in prostate cancer cells. Clin Epigenetics 3(1):3CrossRefPubMedPubMedCentralGoogle Scholar
  51. Hu R, Hebbar V, Kim B-R, Chen C, Winnik B, Buckley B, Soteropoulos P, Tolias P, Hart RP, Kong A-NT (2004) In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat. J Pharmacol Exp Ther 310(1):263–271CrossRefPubMedGoogle Scholar
  52. Hu C, Eggler AL, Mesecar AD, Van Breemen RB (2011) Modification of keap1 cysteine residues by sulforaphane. Chem Res Toxicol 24(4):515–521CrossRefPubMedPubMedCentralGoogle Scholar
  53. Hullar MA, Fu BC (2014) Diet, the gut microbiome, and epigenetics. Cancer J (Sudbury, Mass.) 20(3):170CrossRefGoogle Scholar
  54. Hwang JS, Hwang JS, Chang I, Kim S (2007) Age-associated decrease in proteasome content and activities in human dermal fibroblasts: restoration of normal level of proteasome subunits reduces aging markers in fibroblasts from elderly persons. J Gerontol Ser A Biol Med Sci 62(5):490–499CrossRefGoogle Scholar
  55. Iizumi T, Takahashi S, Mashima K, Minami K, Izawa Y, Abe T, Hishiki T, Suematsu M, Kajimura M, Suzuki N (2016) A possible role of microglia-derived nitric oxide by lipopolysaccharide in activation of astroglial pentose-phosphate pathway via the Keap1/Nrf2 system. J Neuroinflammation 13(1):99CrossRefPubMedPubMedCentralGoogle Scholar
  56. Ishida M, Hara M, Fukino N, Kakizaki T, Morimitsu Y (2014) Glucosinolate metabolism, functionality and breeding for the improvement of Brassicaceae vegetables. Breed Sci 64(1):48–59CrossRefPubMedPubMedCentralGoogle Scholar
  57. Jang M, Cho I-H (2016) Sulforaphane ameliorates 3-nitropropionic acid-induced striatal toxicity by activating the Keap1-Nrf2-ARE pathway and inhibiting the MAPKs and NF-κB pathways. Mol Neurobiol 53(4):2619–2635CrossRefPubMedGoogle Scholar
  58. Jazwa A, Rojo AI, Innamorato NG, Hesse M, Fernández-Ruiz J, Cuadrado A (2011) Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. Antioxid Redox Signal 14(12):2347–2360CrossRefPubMedGoogle Scholar
  59. Jhang KA, Park J-S, Kim H-S, Chong YH (2018) Sulforaphane rescues amyloid-β peptide-mediated decrease in MerTK expression through its anti-inflammatory effect in human THP-1 macrophages. J Neuroinflammation 15(1):75CrossRefPubMedPubMedCentralGoogle Scholar
  60. Jones DP (2015) Redox theory of aging. Redox Biol 5:71–79CrossRefPubMedPubMedCentralGoogle Scholar
  61. Kahn NW, Rea SL, Moyle S, Kell A, Johnson TE (2008) Proteasomal dysfunction activates the transcription factor SKN-1 and produces a selective oxidative-stress response in Caenorhabditis elegans. Biochem J 409(1):205–213CrossRefPubMedGoogle Scholar
  62. Kapeta S, Chondrogianni N, Gonos ES (2010) Nuclear erythroid factor 2 (Nrf2) mediated proteasome activation delays senescence in human fibroblasts. J Biol Chem 285(11):8171–8184CrossRefPubMedPubMedCentralGoogle Scholar
  63. Katsiki M, Chondrogianni N, Chinou I, Rivett AJ, Gonos ES (2007) The olive constituent oleuropein exhibits proteasome stimulatory properties in vitro and confers life span extension of human embryonic fibroblasts. Rejuvenation Res 10(2):157–172CrossRefPubMedGoogle Scholar
  64. Kim J, Lee S, Choi BR, Yang H, Hwang Y, Park JHY, LaFerla FM, Han JS, Lee KW, Kim J (2017) Sulforaphane epigenetically enhances neuronal BDNF expression and TrkB signaling pathways. Mol Nutr Food Res 61(2):1600194CrossRefGoogle Scholar
  65. Kubo E, Chhunchha B, Singh P, Sasaki H, Singh DP (2017) Sulforaphane reactivates cellular antioxidant defense by inducing Nrf2/ARE/Prdx6 activity during aging and oxidative stress. Sci Rep 7(1):14130CrossRefPubMedPubMedCentralGoogle Scholar
  66. Kwak M-K, Wakabayashi N, Greenlaw JL, Yamamoto M, Kensler TW (2003) Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol Cell Biol 23(23):8786–8794CrossRefPubMedPubMedCentralGoogle Scholar
  67. Kwak M-K, Cho J-M, Huang B, Shin S, Kensler TW (2007) Role of increased expression of the proteasome in the protective effects of sulforaphane against hydrogen peroxide-mediated cytotoxicity in murine neuroblastoma cells. Free Radic Biol Med 43(5):809–817CrossRefPubMedGoogle Scholar
  68. Lai R-H, Miller MJ, Jeffery E (2010) Glucoraphanin hydrolysis by microbiota in the rat cecum results in sulforaphane absorption. Food Funct 1(2):161–166CrossRefPubMedGoogle Scholar
  69. Lawrence T (2009) The nuclear factor NF-κB pathway in inflammation. Cold Spring Harb Perspect Biol a001651Google Scholar
  70. Li J, Johnson D, Calkins M, Wright L, Svendsen C, Johnson J (2004) Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells. Toxicol Sci 83(2):313–328CrossRefPubMedGoogle Scholar
  71. Li B, Cui W, Liu J, Li R, Liu Q, Xie X-H et al (2013) Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice. Exp Neurol 250:239–249CrossRefPubMedGoogle Scholar
  72. Li Y, Buckhaults P, Cui X, Tollefsbol TO (2016) Combinatorial epigenetic mechanisms and efficacy of early breast cancer inhibition by nutritive botanicals. Epigenomics 8(8):1019–1037CrossRefPubMedPubMedCentralGoogle Scholar
  73. Liddell J (2017) Are astrocytes the predominant cell type for activation of Nrf2 in aging and neurodegeneration? Antioxidants 6(3):65CrossRefPubMedCentralGoogle Scholar
  74. Liu Y, Liu X, Zhang T, Luna C, Liton PB, Gonzalez P (2007) Cytoprotective effects of proteasome β5 subunit overexpression in lens epithelial cells. Mol Vis 13:31PubMedPubMedCentralGoogle Scholar
  75. Liu Y, Hettinger CL, Zhang D, Rezvani K, Wang X, Wang H (2014) Sulforaphane enhances proteasomal and autophagic activities in mice and is a potential therapeutic reagent for Huntington's disease. J Neurochem 129(3):539–547CrossRefPubMedPubMedCentralGoogle Scholar
  76. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013) The hallmarks of aging. Cell 153(6):1194–1217CrossRefPubMedPubMedCentralGoogle Scholar
  77. Martinez-Villaluenga C, Peñas E, Ciska E, Piskula MK, Kozlowska H, Vidal-Valverde C, Frias J (2010) Time dependence of bioactive compounds and antioxidant capacity during germination of different cultivars of broccoli and radish seeds. Food Chem 120(3):710–716CrossRefGoogle Scholar
  78. Meeran SM, Patel SN, Tollefsbol TO (2010) Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS One 5(7):e11457CrossRefPubMedPubMedCentralGoogle Scholar
  79. Morroni F, Tarozzi A, Sita G, Bolondi C, Moraga JMZ, Cantelli-Forti G, Hrelia P (2013) Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease. Neurotoxicology 36:63–71CrossRefPubMedGoogle Scholar
  80. Myzak MC, Karplus PA, Chung F-L, Dashwood RH (2004) A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res 64(16):5767–5774CrossRefPubMedGoogle Scholar
  81. Myzak MC, Dashwood WM, Orner GA, Ho E, Dashwood RH (2006a) Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc min mice. FASEB J 20(3):506–508CrossRefPubMedPubMedCentralGoogle Scholar
  82. Myzak MC, Ho E, Dashwood RH (2006b) Dietary agents as histone deacetylase inhibitors. Mol Carcinog 45(6):443–446CrossRefPubMedPubMedCentralGoogle Scholar
  83. Nallasamy P, Si H, Babu PVA, Pan D, Fu Y, Brooke EA et al (2014) Sulforaphane reduces vascular inflammation in mice and prevents TNF-α-induced monocyte adhesion to primary endothelial cells through interfering with the NF-κB pathway. J Nutr Biochem 25(8):824–833CrossRefPubMedPubMedCentralGoogle Scholar
  84. Negi G, Kumar A, Sharma S, S. (2011) Nrf2 and NF-κB modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes. Curr Neurovasc Res 8(4):294–304CrossRefPubMedGoogle Scholar
  85. Oeckinghaus A, Ghosh S (2009) The NF-κB family of transcription factors and its regulation. Cold Spring Harbor Perspect Biol a000034Google Scholar
  86. Organization WH (2015) World report on ageing and health. World Health OrganizationGoogle Scholar
  87. Papaevgeniou N, Chondrogianni N (2016) UPS activation in the battle against aging and aggregation-related diseases: an extended review. In: Proteostasis. Springer, pp 1–70Google Scholar
  88. Papaevgeniou N, Sakellari M, Jha S, Tavernarakis N, Holmberg CI, Gonos ES, Chondrogianni N (2016) 18α-Glycyrrhetinic acid proteasome activator decelerates aging and Alzheimer’s disease progression in Caenorhabditis elegans and neuronal cultures. Antioxid Redox Signal 25(16):855–869CrossRefPubMedPubMedCentralGoogle Scholar
  89. Park H-M, Kim J-A, Kwak M-K (2009) Protection against amyloid beta cytotoxicity by sulforaphane: role of the proteasome. Arch Pharm Res 32(1):109–115CrossRefPubMedGoogle Scholar
  90. Paul B, Li Y, Tollefsbol T (2018) The effects of combinatorial genistein and sulforaphane in breast tumor inhibition: role in epigenetic regulation. Int J Mol Sci 19(6):1754CrossRefPubMedCentralGoogle Scholar
  91. Pennisi M, Crupi R, Di Paola R, Ontario ML, Bella R, Calabrese EJ, … Calabrese V (2017) Inflammasomes, hormesis, and antioxidants in neuroinflammation: role of NRLP3 in Alzheimer disease. J Neurosci Res 95(7):1360–1372Google Scholar
  92. Petri N, Tannergren C, Holst B, Mellon FA, Bao Y, Plumb GW, … Knutson L (2003) Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo. Drug Metab Dispos 31(6):805–813Google Scholar
  93. Pickering AM, Linder RA, Zhang H, Forman HJ, Davies KJ (2012) Nrf2-dependent induction of proteasome and Pa28αβ regulator are required for adaptation to oxidative stress. J Biol Chem 287(13):10021–10031CrossRefPubMedPubMedCentralGoogle Scholar
  94. Pontius AT, Smith PW (2011) An antiaging and regenerative medicine approach to optimal skin health. Facial Plast Surg 27(01):029–034CrossRefGoogle Scholar
  95. Poprac P, Jomova K, Simunkova M, Kollar V, Rhodes CJ, Valko M (2017) Targeting free radicals in oxidative stress-related human diseases. Trends Pharmacol Sci 38(7):592–607CrossRefPubMedGoogle Scholar
  96. Prestera T, Zhang Y, Spencer SR, Wilczak CA, Talalay P (1993) The electrophile counterattack response: protection against neoplasia and toxicity. Adv Enzym Regul 33:281–296CrossRefGoogle Scholar
  97. Prochaska HJ, Santamaria AB, Talalay P (1992) Rapid detection of inducers of enzymes that protect against carcinogens. Proc Natl Acad Sci 89(6):2394–2398CrossRefPubMedGoogle Scholar
  98. Pu D, Zhao Y, Chen J, Lv A, Zhu S, Luo C, … Xiao Q (2018) Protective effects of sulforaphane on cognitive impairments and AD-like lesions in diabetic mice are associated with the upregulation of Nrf2 transcription activity. Neuroscience 381:35–45Google Scholar
  99. Royston KJ, Udayakumar N, Lewis K, Tollefsbol TO (2017) A novel combination of withaferin A and sulforaphane inhibits epigenetic machinery, cellular viability and induces apoptosis of breast cancer cells. Int J Mol Sci 18(5):1092CrossRefPubMedCentralGoogle Scholar
  100. Sachdeva MM, Cano M, Handa JT (2014) Nrf2 signaling is impaired in the aging RPE given an oxidative insult. Exp Eye Res 119:111–114CrossRefPubMedGoogle Scholar
  101. Sharpless NE, DePinho RA (2007) How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 8(9):703–713CrossRefPubMedGoogle Scholar
  102. Shih VF-S, Tsui R, Caldwell A, Hoffmann A (2011) A single NFκB system for both canonical and non-canonical signaling. Cell Res 21(1):86–102CrossRefPubMedGoogle Scholar
  103. Shirai Y, Fujita Y, Hashimoto R, Ohi K, Yamamori H, Yasuda Y, … Takeda M (2015) Dietary intake of sulforaphane-rich broccoli sprout extracts during juvenile and adolescence can prevent phencyclidine-induced cognitive deficits at adulthood. PLoS One. 10(6):e0127244Google Scholar
  104. Silva-Palacios A, Ostolga-Chavarria M, Zazueta C, Königsberg M (2018) Nrf2: molecular and epigenetic regulation during aging. Ageing Res Rev 47:31–40CrossRefPubMedGoogle Scholar
  105. Sun S-C (2017) The non-canonical NF-κB pathway in immunity and inflammation. Nat Rev Immunol 17(9):545–558CrossRefPubMedPubMedCentralGoogle Scholar
  106. Sunkaria A, Bhardwaj S, Yadav A, Halder A, Sandhir R (2018) Sulforaphane attenuates postnatal proteasome inhibition and improves spatial learning in adult mice. J Nutr Biochem 51:69–79CrossRefPubMedGoogle Scholar
  107. Talalay P, De Long MJ, Prochaska HJ (1988) Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Proc Natl Acad Sci 85(21):8261–8265CrossRefPubMedGoogle Scholar
  108. Talalay P, Fahey JW, Holtzclaw WD, Prestera T, Zhang Y (1995) Chemoprotection against cancer by phase 2 enzyme induction. Toxicol Lett 82:173–179CrossRefPubMedGoogle Scholar
  109. Talalay P, Fahey JW, Healy ZR, Wehage SL, Benedict AL, Min C, Dinkova-Kostova AT (2007) Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation. Proc Natl Acad Sci 104(44):17500–17505CrossRefPubMedGoogle Scholar
  110. Tonoki A, Kuranaga E, Tomioka T, Hamazaki J, Murata S, Tanaka K, Miura M (2009) Genetic evidence linking age-dependent attenuation of the 26S proteasome with the aging process. Mol Cell Biol 29(4):1095–1106CrossRefPubMedGoogle Scholar
  111. Tortorella SM, Royce SG, Licciardi PV, Karagiannis TC (2015) Dietary sulforaphane in cancer chemoprevention: the role of epigenetic regulation and HDAC inhibition. Antioxid Redox Signal 22(16):1382–1424CrossRefPubMedPubMedCentralGoogle Scholar
  112. Townsend BE, Johnson RW (2016) Sulforaphane induces Nrf2 target genes and attenuates inflammatory gene expression in microglia from brain of young adult and aged mice. Exp Gerontol 73:42–48CrossRefPubMedGoogle Scholar
  113. Verkerk R, Schreiner M, Krumbein A, Ciska E, Holst B, Rowland I, … Mithen R (2009) Glucosinolates in Brassica vegetables: the influence of the food supply chain on intake, bioavailability and human health. Mol Nutr Food Res 53(S2):S219–S219Google Scholar
  114. Vilchez D, Morantte I, Liu Z, Douglas PM, Merkwirth C, Rodrigues AP, … Dillin A (2012) RPN-6 determines C. elegans longevity under proteotoxic stress conditions. Nature 489(7415):263Google Scholar
  115. Vilchez D, Saez I, Dillin A (2014) The role of protein clearance mechanisms in organismal ageing and age-related diseases. Nat Commun 5:5659CrossRefPubMedGoogle Scholar
  116. Winkler S, Faragher J, Franz P, Imsic M, Jones R (2007) Glucoraphanin and flavonoid levels remain stable during simulated transport and marketing of broccoli (Brassica oleracea var. italica) heads. Postharvest Biol Technol 43(1):89–94CrossRefGoogle Scholar
  117. Xu C, Li CY-T, Kong A-NT (2005) Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 28(3):249–268CrossRefPubMedGoogle Scholar
  118. Yang H, Liu F, Li Y, Yu B (2017) Reconstructing biosynthetic pathway of the plant-derived cancer chemopreventive-precursor glucoraphanin in Escherichia coli. ACS Synth Biol 7(1):121–131CrossRefPubMedGoogle Scholar
  119. Zanichelli F, Capasso S, Cipollaro M, Pagnotta E, Cartenì M, Casale F, Iori R, Galderisi U (2012) Dose-dependent effects of R-sulforaphane isothiocyanate on the biology of human mesenchymal stem cells, at dietary amounts, it promotes cell proliferation and reduces senescence and apoptosis, while at anti-cancer drug doses, it has a cytotoxic effect. Age 34(2):281–293CrossRefPubMedGoogle Scholar
  120. Zhang Y, Talalay P, Cho CG, Posner GH (1992) A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci U S A 89(6):2399–2403CrossRefPubMedPubMedCentralGoogle Scholar
  121. Zhang H, Davies KJ, Forman HJ (2015) Oxidative stress response and Nrf2 signaling in aging. Free Radic Biol Med 88:314–336CrossRefPubMedPubMedCentralGoogle Scholar
  122. Zhang J, Zhang R, Zhan Z, Li X, Zhou F, Xing A, Jiang C, Chen Y, An L (2017) Beneficial effects of sulforaphane treatment in Alzheimer’s disease may be mediated through reduced HDAC1/3 and increased P75NTR expression. Front Aging Neurosci 9:121CrossRefPubMedPubMedCentralGoogle Scholar
  123. Zhao Z, Liao G, Zhou Q, Lv D, Holthfer H, Zou H (2016) Sulforaphane attenuates contrast-induced nephropathy in rats via Nrf2/HO-1 pathway. Oxidative Med Cell LongevGoogle Scholar
  124. Zhao F, Zhang J, Chang N (2018) Epigenetic modification of Nrf2 by sulforaphane increases the antioxidative and anti-inflammatory capacity in a cellular model of Alzheimer’s disease. Eur J Pharmacol 824:1–10CrossRefPubMedGoogle Scholar
  125. Zhou Q, Chen B, Wang X, Wu L, Yang Y, Cheng X, … Sun X (2016) Sulforaphane protects against rotenone-induced neurotoxicity in vivo: involvement of the mTOR, Nrf2, and autophagy pathways. Sci Rep 6:32206Google Scholar
  126. Zhou L, Zhang H, Davies KJ, Forman HJ (2018) Aging-related decline in the induction of Nrf2-regulated antioxidant genes in human bronchial epithelial cells. Redox Biol 14:35–40CrossRefPubMedGoogle Scholar
  127. Zhu M, Zhang Y, Cooper S, Sikorski E, Rohwer J, Bowden GT (2004) Phase II enzyme inducer, sulforaphane, inhibits UVB-induced AP-1 activation in human keratinocytes by a novel mechanism. Mol Carcinog 41(3):179–186CrossRefPubMedGoogle Scholar

Copyright information

© American Aging Association 2019

Authors and Affiliations

  • Roberto Santín-Márquez
    • 1
    • 2
  • Adriana Alarcón-Aguilar
    • 1
  • Norma Edith López-Diazguerrero
    • 1
  • Niki Chondrogianni
    • 3
  • Mina Königsberg
    • 1
    Email author
  1. 1.Departamento de Ciencias de la Salud, División de Ciencias Biológicas y de la SaludUniversidad Autónoma Metropolitana-IztapalapaMexico CityMexico
  2. 2.Posgrado en Biología ExperimentalUniversidad Autónoma Metropolitana-IztapalapaMexico CityMexico
  3. 3.National Hellenic Research FoundationInstitute of Biology, Medicinal Chemistry and BiotechnologyAthensGreece

Personalised recommendations